Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Cabot Corporation Q2 FY2026 Earnings Call - Battery Materials Surge Masks Reinforcement Materials Weakness
Cabot Corporation delivered a mixed second quarter of fiscal 2026, with adjusted EPS declining 15% year-over-year to $1.61 as the Reinforcement Materials segment struggled with lower gross profit per ...
- Cabot reported adjusted EPS of $1.61 for Q2 FY2026, a 15% decline from the prior year, as weakness in the Reinforcement Materials segment outweighed strength in Performance Chemicals.
- Reinforcement Materials EBIT fell 29% to $93 million, driven by lower gross profit per ton from calendar year 2026 customer agreements and intensified competition in Asia Pacific.
- Performance Chemicals segment delivered robust results with EBIT rising 18% to $59 million, supported by improved product mix and optimization efforts.
- +7 more takeaways
"Lifecore Biomedical" Q1 2026 Earnings Call - Revenue Misses as Headwinds Front-Load, Pipeline Momentum Builds
Lifecore Biomedical reported a sharp Q1 2026 revenue decline of 34% to $23.2 million, as previously announced supply chain disruptions and a customer agreement termination front-loaded their full-year...
- Q1 2026 revenue fell 34% year-over-year to $23.2 million, driven by the front-loading of supply chain disruptions and a terminated customer agreement that management had warned about in Q4 2025.
- Management reaffirmed full-year 2026 guidance, expecting revenue between $120 million and $125 million, with a 40/60 split favoring the second half of the year.
- Adjusted EBITDA contracted significantly to $1 million in Q1, down from $5.7 million in the prior year quarter, as lower revenues offset recent cost-cutting efforts.
- +9 more takeaways
Enact Holdings Q1 2026 Earnings Call - Strong Capital Returns and Resilient Credit Performance Amid Rate Volatility
Enact Holdings delivered a resilient first quarter in 2026, generating $172 million in adjusted operating income and $1.21 in diluted earnings per share. The company wrote $13 billion in new insurance...
- Enact reported adjusted operating income of $172 million and $1.21 in diluted earnings per share for Q1 2026, up from $1.10 per share in the prior year period.
- New insurance written reached $13 billion, driving total insurance in force to $272 billion, with persistency holding strong at 80% due to favorable loan equity profiles.
- Credit performance remains solid, with new delinquencies down 1% sequentially and cure rates up 13%, resulting in a $39 million net reserve release and a 15% loss ratio.
- +7 more takeaways
CLEAR Inc Q1 2026 Earnings Call - CLEAR1 Bookings Surge 5x, Free Cash Flow Guidance Raised to $465M
CLEAR delivered a definitive Q1 2026 that validated its pivot from an airport convenience play to foundational identity infrastructure. The company reported record revenue of $253 million and bookings...
- Revenue grew 19.7% year-over-year to $253 million, while total bookings surged 40.8% to $291.7 million, reflecting strong underlying demand across both travel and enterprise segments.
- CLEAR1 bookings grew approximately 5x year-over-year, marking a record quarter for the enterprise identity platform as organizations urgently seek to combat AI-driven fraud and identity theft.
- Management raised full-year 2026 free cash flow guidance by $25 million to at least $465 million, representing over 36% year-over-year growth and validating the company's operating leverage.
- +9 more takeaways
The New York Times Company Q1 2026 Earnings Call - Digital Ads Surge 32% as Subscription Growth Accelerates
The New York Times delivered a standout first quarter in 2026, driven by a 16% jump in digital subscription revenue and a 32% surge in digital advertising that easily beat management expectations. The...
- Digital subscription revenue grew 16% year-over-year to $389 million, adding 310,000 net new subscribers and pushing the total base past 13 million.
- Total subscription revenue rose 11.3% to approximately $517 million, outperforming the prior guidance range.
- Digital advertising revenue surged 32% to $93 million, significantly exceeding management expectations and driven by strong marketer demand.
- +9 more takeaways
Reynolds Consumer Products Q1 2026 Earnings Call - Strong Start to 2026 Amidst Inflationary Headwinds and Strategic Realignment
Reynolds Consumer Products delivered a robust first quarter in 2026, posting 7% revenue growth to $877 million and expanding adjusted EBITDA by 12% to $131 million. The company successfully navigated ...
- Revenue grew 7% year-over-year to $877 million, driven by strong volume growth of 2% and successful price implementations.
- Adjusted EBITDA rose 12% to $131 million, exceeding expectations and reflecting improved manufacturing efficiency and gross margin expansion of approximately 60 basis points.
- The company gained share across the majority of its portfolio, outperforming its categories by two percentage points despite a highly promotional environment.
- +7 more takeaways
Pitney Bowes Q1 2026 Earnings Call - Cash Flow Surge and Presort Turnaround Signal Strategic Shift
Pitney Bowes delivered a strong first quarter, marked by a dramatic turnaround in free cash flow and rising momentum across its core SendTech and Presort segments. The company raised its full-year gui...
- Free cash flow surged to $43.5 million in Q1, a massive reversal from consensus estimates of a $14 million outflow, driven by disciplined working capital management and strong operating performance.
- Full-year guidance was raised, with management citing improving momentum in both SendTech and Presort, and expecting Presort volume growth to return in the third quarter.
- SendTech revenue declined less than 1% year-over-year, marking a significant slowdown in the decline, supported by renewed sales aggression, predictive customer retention, and product simplification.
- +7 more takeaways
Flowco Holdings Inc Q1 2026 Earnings Call - Valiant Acquisition Drives Rental Revenue Growth Amidst Geopolitical Supply Shocks
Flowco delivered a solid Q1 2026, landing at the upper end of guidance with adjusted EBITDA of $85.5 million and strong free cash flow generation of $52 million. The company successfully integrated th...
- Adjusted EBITDA reached $85.5 million, at the upper end of the guidance range, driven by strong execution across both operating segments and a full month of contribution from the Valiant acquisition.
- Free cash flow generation was robust at $52 million, enabling debt reduction and continued capital returns to shareholders through dividends and share repurchases.
- The acquisition of Valiant Artificial Lift Solutions closed in early March, expanding Flowco's capabilities into the ESP market and adding approximately $50 million in working capital.
- +7 more takeaways
Wayne Bank Q1 2026 Earnings Call - Record Net Interest Income and Faster Presence Bank Accretion
Wayne Bank kicked off 2026 with record net interest income of $24.6 million, driven by a 38 basis point margin expansion to 3.68% and the full quarter inclusion of the Presence Bank acquisition. The b...
- Record net interest income of $24.6 million, up 38% year-over-year, with a 3.68% margin expansion.
- Presence Bank acquisition fully integrated into Q1 results, boosting assets and earnings power.
- Tangible book value payback from the merger expected to accelerate ahead of original projections.
- +9 more takeaways
Geron Corporation Q1 2026 Earnings Call - Rytelo Revenue Surges 31% as Europe Strategy Takes Shape
Geron Corporation delivered a strong first quarter in 2026, with Rytelo net revenue climbing 31% year-over-year to $61.8 million, positioning the biotech well within its updated annual guidance of $22...
- Rytelo Q1 2026 net revenue reached $61.8 million, up 31% year-over-year and 8% quarter-over-quarter, keeping the company on track for its full-year guidance of $220 million to $240 million.
- Geron is doubling down on the lower-risk MDS second-line patient segment, which management estimates at approximately 8,000 eligible patients in the U.S., supported by NCCN guidelines and real-world data.
- Gross-to-net reductions expanded to 21% in Q1 from 13% in Q1 2025, driven by wider 340B utilization and GPO contracting, with full-year expectations in the low to mid 20s.
- +7 more takeaways